OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial
Atefeh Zandifar, Maryam Panahi, Rahim Badrfam, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Atefeh Zandifar, Maryam Panahi, Rahim Badrfam, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 2
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 2
The interface of depression and diabetes: treatment considerations
Giuseppe Fanelli, Emanuel Raschi, Gaye Hafez, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Giuseppe Fanelli, Emanuel Raschi, Gaye Hafez, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Sodium‐glucose cotransporter 1/2 inhibition and risk of neurodegenerative disorders: A Mendelian randomization study
Jinxin Liu, Xinxiu Shi, Yankun Shao
Brain and Behavior (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 5
Jinxin Liu, Xinxiu Shi, Yankun Shao
Brain and Behavior (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 5
Risk of depression and dementia among individuals treated with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists
Osvaldo P. Almeida
Current Opinion in Psychiatry (2025)
Closed Access
Osvaldo P. Almeida
Current Opinion in Psychiatry (2025)
Closed Access
The potential neuroprotective effect of empagliflozin against depressive-like behavior induced by chronic unpredictable mild stress in rats: Involvement of NLRP3 inflammasome
Marwa A. Ali, Haidy E. Michel, Esther T. Menze, et al.
European Journal of Pharmacology (2025), pp. 177525-177525
Closed Access
Marwa A. Ali, Haidy E. Michel, Esther T. Menze, et al.
European Journal of Pharmacology (2025), pp. 177525-177525
Closed Access
New Insights in Psychiatric Disorder Psychopharmacology
Mohammadreza Shalbafan, Laura Orsolini
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 319-319
Open Access
Mohammadreza Shalbafan, Laura Orsolini
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 319-319
Open Access
Neuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review
Andreea Sălcudean, Cristina-Raluca Bodo, Ramona Amina Popovici, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 502-502
Open Access
Andreea Sălcudean, Cristina-Raluca Bodo, Ramona Amina Popovici, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 502-502
Open Access
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
Matteo Armillotta, Francesco Angeli, Pasquale Paolisso, et al.
Pharmacology & Therapeutics (2025) Vol. 270, pp. 108861-108861
Open Access
Matteo Armillotta, Francesco Angeli, Pasquale Paolisso, et al.
Pharmacology & Therapeutics (2025) Vol. 270, pp. 108861-108861
Open Access
